IOL Chemicals and Pharmaceuticals Limited has reported Consolidated financial results for the period ended June 30, 2023.

IOL Chemicals and Pharmaceuticals has posted net profit of Rs. 45.86 crores for the period ended June 30, 2023 as against net profit of Rs. 64.78 crores for the period ended March 31, 2023. The company posted net profit of Rs.34.67 crores for the period ended June 30, 2022.

IOL Chemicals and Pharmaceuticals has reported total income of Rs. 570.24 crores during the period ended June 30, 2023 as compared to Rs. 595.94 crores during the period ended March 31, 2023. The company reported total income of Rs.570.17 crores during the period ended June 30, 2022.

Commenting on the performance, Vikas Gupta, Joint Managing Director, said “We are pleased to report sustainable performance during the 1 st quarter of FY24, tackling present challenges while positioning ourselves for forthcoming opportunities. We are hopeful for increased presence in regulatory market as the Company got CEP for paracetamol. Additionally, with the commencement of Acetic Anhydride plant, focus on improved efficiencies, product mix and timely execution we are hopeful to generate strong cash flow”.